Functional recovery results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

(2011) Rosario de Arce Cordón et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

(2010) Wolfgang Gaebel et al.   NEUROPSYCHOPHARMACOLOGY

Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder

(2009) Diana O. Perkins et al.   JOURNAL OF CLINICAL PSYCHIATRY

Sedation as a Side Effect of the Treatment of Mental Disorders

(2009) John M. Kane   JOURNAL OF CLINICAL PSYCHIATRY

Long-Acting Injectable Risperidone in the Treatment of Subjects With Recent-Onset Psychosis

(2009) Robin Emsley et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study

(2009) David Hough et al.   SCHIZOPHRENIA RESEARCH

Better pharmacotherapy for schizophrenia: What does the future hold?

(2008) Michael A. Webber et al.   Current Psychiatry Reports

Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia

(2007) Hirofumi Aki et al.   PSYCHIATRY RESEARCH